Carrillo ER, Sosa GJO, Carrillo CJR, Carrillo CLD, Uribe EM

Language: Spanish
References: 13
Page: 432-442
PDF size: 572.68 Kb.

ABSTRACT

Influenza is a highly contagious acute respiratory disease caused by different subtypes of virus. Recently, an epidemic of the human influenza virus A started in Mexico, and it was also detected in several other countries around the world. To address this epidemiological emergency, Medica Sur Clinic Foundation has implemented a comprehensive contingency plan based on World Health Organization (WHO), Panamerican Health Organization (PAHO) and Ministry of Health recommendations , which goal was to confront and contain the outbreak of human influenza A H1N1, attending efficiently, and with high degrees of quality and safety to all who sought medical care while protecting the medical staff and paramedics. In order to achieve this, the Sanitary Emergency Committee was established with hospital authorities and Intensive Care, Infectious Diseases, Nursing, Emergency, Laboratory, Radiology, Informatics, Education, Hospitalization and various support services. During the contingency period, 2944 patients were admitted in the Emergency department, only 118 of which required to be hospitalized. Twenty three patients (16 adults, 7 children) tested positive for human influenza A H1N1 virus. The mortality rate was 0.06%. With the security measures implemented, there were no cases of influenza among the hospital staff. During the current outbreak, we assessed our response capability and organization, resulting in a viable project that gave excellent results and can turn into a model for other institutions.

REFERENCES

1. Ayora TG. Influenza: Historia de una enfermedad. Rev Biomed 1999;10:57-61

2. United States Centers for Disease Control and Prevention. Interim guidance on antiviral recommendations for patients with novel influenza A (H1N1) virus infection and their close contacts. http://www.cdc.gov/h1n1flu/recommendations.htm

3. World Health Organization. Swine flu illness in the United States and Mexico. Update 2, 26 April 2009. http://www.who.int/csr/don/2009_04_26/en/index.htlm

4. Myers KP, Olsen CW, Gray GC. Cases of swine influenza in humans: a review of literature. Clin Infect Dis 2007;44:1084-1089.

5. Ananthan D, McHugh W, O’Neill S, Forrow L. Clinical review: influenza pandemic-physicians and their obligations. Crit Care 2008;12:217-222.

6. Collins N, Litt J, Moore M, Winzenberg T, Shaw K. General practice: Professional preparation for a Pandemic. Med J Aust 2006;185: 66-69.

7. Aledort JE, Lurie N, Wasserman J, Bozzete SA. Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base. BMC Public Health 2007;7:208-211

8. Couzin-Frankel J. Swine flu outbreak. What role for antiviral drugs. Science 2009;324:705-709.

9. Reina J. Detection of oseltamivir resistance among human influenza A (H1N1) strains isolated in 2007-2008 flu season. Med Clin 2008;131:63-64.

10. Bassin CR, Bielefeldt-Ohmann H, Tumpey TM, et al. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci 2009;106:3455-3460.

11. Us D. Cytokine storm in avian influenza. Miktobiyol Bul 2008;42:365-389.

12. Chan MCW, Cheung CY, Chui WH, Tsao SW, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 2005;6:135-141.

13. Malm H, May T, Francis LP, et al. Ethics, pandemics, and the duty to treat. Am J Bioeth 2008;8:4-19.